General Information of DTT (ID: TTF4CAM)

DTT Name Influenza Hemagglutinin (Influ HA) DTT Info
Gene Name Influ HA

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arbidol DMOQK8Z Virus infection 1A24-1D9Z Approved [1]
------------------------------------------------------------------------------------
7 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
CR8020 DMQ47U6 Influenza virus infection 1E30-1E32 Phase 2 [2]
RG7745 DMK5PYS Infectious disease 1A00-CA43.1 Phase 2 [3]
VIS410 DM1G6ME Influenza A virus infection 1E30 Phase 2 [4]
A/Anhui/05 DMGJ7A4 Influenza virus infection 1E30-1E32 Phase 1 [5]
ND-1.1 DMVQAEK Influenza virus infection 1E30-1E32 Phase 1 [6]
VGX-3400 DMGMEH7 Influenza A virus H5N1 infection 1E30 Phase 1 [7]
VIR-2482 DM6LQIU Influenza A virus infection 1E30 Phase 1 [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Clinical Trial Drug(s)
6 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
2-tert-butylbenzene-1,4-diol DMNXI1E Discovery agent N.A. Investigative [9]
Alpha-D-Mannose DMF5DLW Discovery agent N.A. Investigative [10]
BMY-27709 DMAMYWL Discovery agent N.A. Investigative [11]
CL 385319 DML8MSC Discovery agent N.A. Investigative [11]
PXVX-0103 DM2P0I4 Discovery agent N.A. Investigative [12]
Stachyflin DMIZESL Discovery agent N.A. Investigative [11]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Investigative Drug(s)
Molecule Interaction Atlas

References

1 Pharmacokinetic properties and bioequivalence of two formulations of arbidol: an open-label, single-dose, randomized-sequence, two-period crossover study in healthy Chinese male volunteers. Clin Ther. 2009 Apr;31(4):784-92.
2 Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin. J Virol. 2014 Dec;88(23):13580-92.
3 Clinical pipeline report, company report or official report of Roche.
4 Clinical pipeline report, company report or official report of Visterra.
5 A Human Antibody Recognizing a Conserved Epitope of H5 Hemagglutinin Broadly Neutralizes Highly Pathogenic Avian Influenza H5N1 Viruses. J Virol. 2012 March; 86(6): 2978-2989.
6 An adenovirus-based vaccine with a double-stranded RNA adjuvant protects mice and ferrets against H5N1 avian influenza in oral delivery models. Clin Vaccine Immunol. 2013 Jan;20(1):85-94.
7 Clinical pipeline report, company report or official report of Inovio Pharmaceuticals.
8 Clinical pipeline report, company report or official report of Vir Biotechnology.
9 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
10 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
11 Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion. Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17736-41.
12 Company report (PaxVax)